期刊文献+

围孕期高催乳素血症的诊治与管理

Diagnosis and treatment of hyperprolactinemia during periconception
原文传递
导出
摘要 高催乳素血症是临床常见的一种病理生理状态,可由多种生理、病理、药物因素引起,常常导致闭经、溢乳和不孕,多数患者经药物治疗有效并恢复生育能力。高催乳素血症患者的妊娠时机、合并垂体催乳素瘤孕期多巴胺受体激动剂使用原则及孕期监护等均是医患关注重点。本文根据不同原因所致妊娠合并高催乳素血症的诊断及孕前、孕期与产后管理分别进行阐述,以协助临床决策。 Hyperprolactinemia represents a commonly encountered pathological physiological condition in clinical practice. It should be emphasized that hyperprolactinemia is not considered a distinct disease, but rather a physiological state that can be induced by various factors including physiological, pathological, and pharmacological causes. This condition often leads to menstrual irregularities, galactorrhea, and infertility. The majority of patients respond favorably to pharmacological interventions, resulting in the restoration of their reproductive capabilities. However, healthcare providers and patients need to pay particular attention to key aspects such as determining the appropriate time of pregnancy in individuals with hyperprolactinemia, principles for using dopamine agonists (DAs) during pregnancy in those with concurrent pituitary prolactinomas, as well as monitoring during the antenatal period. This article elucidates the diagnosis and management of hyperprolactinemia combined with pregnancy due to different etiologies, addressing preconception care, antenatal management, and postnatal considerations. Its purpose is to facilitate informed clinical decision-making.
作者 周杨 吕淑兰 Zhou Yang;Lyu Shulan
出处 《中华产科急救电子杂志》 2024年第1期24-28,共5页 Chinese Journal of Obstetric Emergency(Electronic Edition)
基金 陕西省重点研发计划(2022SF-163)。
关键词 高催乳素血症 妊娠 诊断 治疗学 Hyperprolactinemia Pregnancy Diagnosis Herapeutics
  • 相关文献

参考文献1

二级参考文献12

  • 1贺又娥,张以文.子宫内膜异位症患者泌乳素分泌功能及其与黄体功能不足和不...[J].中华妇产科杂志,1993,28(1):14-17. 被引量:13
  • 2Melmed S, Casanueva FF, Hoffman AR, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society Clinical Practice Guideline[J]. J Clin Endocrinol Metab, 201 l, 96(2):273-288. DOI: 10.1210@.2010-1692. 被引量:1
  • 3Schulz KD, Geiger W, del Pozo E, et al. Pattern of sexual steroids, prolaetin, and gonadotropie hormones duringprolactin inhibition in normally cycling women[J]. Am J Obstet Gynecol, 1978, 132(5):561-566. 被引量:1
  • 4Molitch ME. Prolactin in human reproduction[M]//Strauss JF, Barbieri RL. Yen and Jaffe' s reproductive endocrinology: physiology, pathophysiology and clinical management. 5th ed. Philadelphia: Elsevier Saunders, 2004:93-123. 被引量:1
  • 5Casanueva FF, Molitch ME, Schlechte JA, et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas[J]. Clin Endocrinol (Oxf), 2006, 65(2):265-273. 被引量:1
  • 6Serri O, Chick CL, Ur E, et al. Diagnosis and management of hyperprolactinemia[J]. CMAJ, 2003, 169(6):575-581. 被引量:1
  • 7Faglia G, Conti A, Muratori M, et al. Dihydroergocriptine in management of mieroprolactinomas[J]. J Clin Endocrinol Metab, 1987, 65(4):779-784. 被引量:1
  • 8Pereira AM. Update on the withdrawal of dopamine agonists in patients with hyperprolactinemia[J]. Curt Opin Endocrinol Diabetes Obes,2011,18(4):264-268.DOI: 10.1097/MED.0b013e 328347c94a. 被引量:1
  • 9张以文.溴隐亭治疗异常泌乳合并无排卵:附53例分析[J].中华妇产科杂志,1985,20(3):135-139. 被引量:1
  • 10高催乳素血症诊疗共识[J].中华妇产科杂志,2009,44(9):712-718. 被引量:13

共引文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部